Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab pilot study on endothelial function in active rheumatoid arthritis
NL-OMON36186Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by University Medical Center Groningen. Primary endpoint: Endothelial dysfunction. Started Jun 2011; status: active, not recruiting.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON36186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36186.